Filed (PHiled). Greater than 1-2 years since publication Archives - Page 142 of 150

Health-related quality of life and parental depression in children with pulmonary arterial hypertension

Fatma H. Canbeyli, Vildan Atasayan, Semiha Tokgoz, Fatma S. Tunaoglu, Ayse D. Oguz, Bulent Celik, Serdar KulaKırıkkale University. Umraniye Training and Research Hospital. Gazi University.Turkey Pediatric PulmonologyPediatr Pulmonol 2022; 57: 544-550DOI: 10.1002/ppul.25777 AbstractBackground: Impaired health-related quality of life (HRQoL) is a common problem in pulmonary arterial hypertension (PAH), but there is limited data on HRQoL in children […]

Assessment of Quality of Life in Children With Pulmonary Hypertension Using Parent and Self-report Questionnaires

László Ablonczy, Zita Mayer, Orsolya Somoskövi, Andrea Berkes, Orsolya Csenteri, Eva Kis, György S. ReuszGottsegen National Cardiovascular Center. University of Debrecen Clinical Center. Semmelweis University.Hungary Transplantation ProceedingsTransplant Proc 2022; 54: 2598-2602DOI: 10.1016/j.transproceed.2022.10.051 AbstractPulmonary arterial hypertension (PAH) is a progressive disease characterized by elevation of pulmonary vascular resistance and right ventricular failure. By using advanced therapies to reduce mortality, clinicians focus on improving functional status and quality of life (QOL).

Assessment of Quality of Life in Children With Pulmonary Hypertension Using Parent and Self-report Questionnaires Read More »

Pregnancy and pulmonary arterial hypertension-improving surveillance and outcomes with multidisciplinary care and N terminal pro-brain natriuretic peptide trends

Cini Sudhakara Prasad, Shine Kumar, Sudha Sumathy, Radhamony Kunjukutty, Nitu Puthenveettil, Amitabh Chanchal Sen, Jeya Bawani Sivabalakrishnan, Rama Krishna KumarAmrita Institute of Medical Sciences and Amrita Vishwa Vidyapeetham University. Sultan Qaboos University Hospital. India Journal of Maternal-Fetal and Neonatal MedicineJ Matern Fetal Neonat Med 2022; 35: 3533-3539DOI: 10.1080/14767058.2020.1828333 AbstractObjective: To describe maternal and fetal outcomes and N

Pregnancy and pulmonary arterial hypertension-improving surveillance and outcomes with multidisciplinary care and N terminal pro-brain natriuretic peptide trends Read More »

PATET ratio by Doppler echocardiography: noninvasive detection of pediatric pulmonary arterial hypertension

Jennifer K. Trittmann, Hanadi Almazroue, Leif D. Nelin, Terri A. Shaffer, Charanda R. Celestine, Henry W. Green, Raphael A. MalbrueOhio State University and Nationwide Children’s Hospital.United States Pediatric ResearchPediatr Res 2022; 92: 631-636DOI: 10.1038/s41390-021-01840-9 AbstractPulmonary artery acceleration time (PAT) and PAT: ejection time (PATET) ratio are echocardiographic measurements of pulmonary arterial hypertension (PAH). These noninvasive quantitative

PATET ratio by Doppler echocardiography: noninvasive detection of pediatric pulmonary arterial hypertension Read More »

Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension

Samuel J. Gentle, Colm P. Travers, Matthew Clark, Waldemar A. Carlo, Namasivayam AmbalavanamUniversity of Alabama at Birmingham.United States American Journal of Respiratory and Critical Care MedicineAm J Respir Crit Care Med 2022; DOI: 10.1164/rccm.202203-0570OC AbstractBackground: Extremely preterm infants with evolving bronchopulmonary dysplasia (BPD) are at risk for development of BPD-associated pulmonary hypertension (BPD-PH). The presence and duration

Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension Read More »

ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery

Dana P. McGlothlin, John Granton, Walter Klepetko, Maurice Beghetti, Erika B. Rosenzweig, Paul A. Corris, Evelyn Horn, Manreet K. Kanwar, Karen McRae, Antonio Roman, Ryan Tedford, Roberto Badagliacca, Sonja Bartolome, Raymond Benza, Marco Caccamo, Rebecca Cogswell, Celine Dewachter, Laura Donahoe, Elie Fadel, Harrison W. Farber, Jeffrey Feinstein, Veronica Franco, Robert Frantz, Michael Gatzoulis, Choon Hwa

ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery Read More »

Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine

Johannes M. Douwes, Willemijn M. H. Zijlstra, Erika B. Rosenzweig, Mark-Jan Ploegstra, Usha S. Krishnan, Meindina G. Haarman, Marcus T. R. Roofthooft, Douwe Postmus, Hans L. Hillege, D. Dunbar Ivy, Rolf M. F. BergerUniversity of Groningen, University Medical Center Groningen and Beatrix Children’s Hospital. Columbia University. University of Colorado, Children’s Hospital Colorado.Netherlands and United States

Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine Read More »

Clinical differences between children and adults with idiopathic and heritable pulmonary arterial hypertension

Shinichi Takatsuki, Hiroto Shimokawahara, Yukira Shimizu, Reiko Kawai, Hiroyuki Matsuura, Hiromi MatsubaraToho University Omori Medical Center. National Hospital Organization Okayama Medical Center.Japan Cardiology in the YoungCardiol Young 2022; DOI: 10.1017/S1047951122003432 AbstractBackground: Although previous studies have demonstrated that paediatric pulmonary arterial hypertension remains distinct from that in adults, there are limited studies evaluating a direct comparison between children

Clinical differences between children and adults with idiopathic and heritable pulmonary arterial hypertension Read More »

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope

Alexandra N. Linder, Jill Hsia, Sheila V. Krishnan, Erika B. Rosenzweig, Usha S. KrishnanColumbia University Irving Medical Center and New York Presbyterian Hospital. Children’s Hospital of Philadelphia, Philadelphia. Stonybrook University School of Medicine.United States European Respiratory Journal Open ResearchERJ Open Res 2022; 8: DOI: 10.1183/23120541.00223-2022 AbstractBackground: Syncope in Group 1 pulmonary arterial hypertension (PAH) is an independent

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope Read More »

Long-term prognostic value of cardiac catheterization and acute vasodilator testing with inhaled iloprost in pediatric idiopathic pulmonary arterial hypertension

Chen Zhang, Konstantinos Dimopoulos, Qiangqiang Li, Hong GuBeijing Anzhen Hospital, Capital Medical University. Royal Brompton Hospital.China and United Kingdom Pulmonary Circulation Pulm Circ 2022; 12: DOI: 10.1002/pul2.12169 AbstractTo assess the long-term prognostic value of cardiac catheterization and acute vasodilator testing (AVT) with inhaled iloprost in children with idiopathic pulmonary arterial hypertension (IPAH). Data on 81 consecutive

Long-term prognostic value of cardiac catheterization and acute vasodilator testing with inhaled iloprost in pediatric idiopathic pulmonary arterial hypertension Read More »